Gene Page:CDC16
概括?
| 基因 | 8881 |
| Symbol | CDC16 |
| Synonyms | ANAPC6|APC6|CDC16Hs|CUT9 |
| Description | cell division cycle 16 |
| Reference | MIM:603461|HGNC:HGNC:1720|Ensembl:ENSG00000130177|HPRD:04587|Vega：Otthumg0000000017402 |
| Gene type | protein-coding |
| Map location | 13Q34 |
| Pascal p-value | 0.008 |
| Sherlock p-value | 0.685 |
| Fetal beta | 0.437 |
| eGene | Cerebellar Hemisphere Cerebellum Myers' cis & trans |
数据源中的基因
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV：GWASDB | Genome-wide Association Studies | GWASdb records for schizophrenia | |
| CV:PGCnp | Genome-wide Association Study | GWAS |
第一节遗传学和表观遗传学注释
eQTL annotation
eQTL annotation| SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
|---|---|---|---|---|---|---|---|---|
| rs10180903 | chr2 | 223115728 | CDC16 | 8881 | 0.15 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
脚注：
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
脚注：
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
| Top 10 positively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| C8orf46 | 0.77 | 0.79 |
| AK5 | 0.77 | 0.80 |
| CHN1 | 0.76 | 0.82 |
| ANXA7 | 0.76 | 0.79 |
| C13orf36 | 0.76 | 0.70 |
| AGBL4 | 0.75 | 0.73 |
| HPRT1 | 0.75 | 0.71 |
| KCNK1 | 0.75 | 0.78 |
| NAPB | 0.75 | 0.69 |
| MAP2K1 | 0.74 | 0.70 |
| Top 10 negatively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| BCL7C | -0.52 | -0.67 |
| SH3BP2 | -0.50 | -0.63 |
| SH2B2 | -0.49 | -0.63 |
| KIAA1949 | -0.49 | -0.53 |
| TRAF4 | -0.48 | -0.63 |
| SH2D2A | -0.48 | -0.57 |
| TUBB2B | -0.47 | -0.57 |
| PKN1 | -0.47 | -0.54 |
| PDE9A | -0.47 | -0.59 |
| PPP1R14B | -0.46 | -0.61 |
Section IV. Protein-protein interaction annotation
| Interactors | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
|---|---|---|---|---|---|
| ANAPC1 | APC1 | MCPR | TSG24 | anaphase promoting complex subunit 1 | 共纯化 | BioGRID | 11076961 |
| ANAPC4 | APC4 | anaphase promoting complex subunit 4 | Affinity Capture-Western | BioGRID | 12956947 |
| ANAPC5 | APC5 | anaphase promoting complex subunit 5 | - | HPRD,BioGRID | 10922056 |
| APC2 | APCL | adenomatosis polyposis coli 2 | Affinity Capture-Western | BioGRID | 12956947 |
| BUB1B | BUB1beta | BUBR1 | Bub1A | MAD3L | SSK1 | hBUBR1 | budding uninhibited by benzimidazoles 1 homolog beta (yeast) | - | HPRD,BioGRID | 10477750 |
| CDC20 | CDC20A | MGC102824 | bA276H19.3 | p55CDC | cell division cycle 20 homolog (S. cerevisiae) | - | HPRD,BioGRID | 9628895|12196507 |
| CDC27 | APC3 | CDC27Hs | D0S1430E | D17S978E | HNUC | cell division cycle 27 homolog (S. cerevisiae) | - | HPRD,BioGRID | 9405394 |
| CDH1 | Arc-1 | CD324 | CDHE | ECAD | LCAM | UVO | cadherin 1, type 1, E-cadherin (epithelial) | Reconstituted Complex | BioGRID | 12956947 |
| MAD2L1 | HSMAD2 | MAD2 | MAD2 mitotic arrest deficient-like 1 (yeast) | - | HPRD | 9628895 |
| PPP5C | FLJ36922 | PP5 | PPP5 | protein phosphatase 5, catalytic subunit | - | HPRD | 9405394 |
| SKIL | SNO | SnoA | SnoN | SKI-like oncogene | - | HPRD | 11691834 |
| SMAD2 | JV18 | JV18-1 | MADH2 | MADR2 | MGC22139 | MGC34440 | hMAD-2 | hSMAD2 | SMAD家庭成员2 | - | HPRD,BioGRID | 11691834 |
| SMAD3 | DKFZp586N0721 | DKFZp686J10186 | HSPC193 | HsT17436 | JV15-2 | MADH3 | MGC60396 | SMAD家庭成员3 | - | HPRD,BioGRID | 11691834 |
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| KEGG CELL CYCLE | 128 | 84 | 该途径中的所有SZGR 2.0基因 |
| KEGG OOCYTE MEIOSIS | 114 | 79 | 该途径中的所有SZGR 2.0基因 |
| KEGG UBIQUITIN MEDIATED PROTEOLYSIS | 138 | 98 | 该途径中的所有SZGR 2.0基因 |
| KEGG PROGESTERONE MEDIATED OOCYTE MATURATION | 86 | 59 | 该途径中的所有SZGR 2.0基因 |
| REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 24 | 12 | 该途径中的所有SZGR 2.0基因 |
| REACTOME CELL CYCLE | 421 | 253 | 该途径中的所有SZGR 2.0基因 |
| REACTOME CELL CYCLE MITOTIC | 325 | 185 | 该途径中的所有SZGR 2.0基因 |
| REACTOME CELL CYCLE CHECKPOINTS | 124 | 70 | 该途径中的所有SZGR 2.0基因 |
| REACTOME REGULATION OF MITOTIC CELL CYCLE | 85 | 46 | 该途径中的所有SZGR 2.0基因 |
| REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 72 | 38 | 该途径中的所有SZGR 2.0基因 |
| REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | 73 | 40 | 该途径中的所有SZGR 2.0基因 |
| REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | 64 | 34 | 该途径中的所有SZGR 2.0基因 |
| REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 26 | 10 | 该途径中的所有SZGR 2.0基因 |
| REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 22 | 9 | 该途径中的所有SZGR 2.0基因 |
| REACTOME IMMUNE SYSTEM | 933 | 616 | 该途径中的所有SZGR 2.0基因 |
| REACTOME PHOSPHORYLATION OF THE APC C | 23 | 10 | 该途径中的所有SZGR 2.0基因 |
| REACTOME适应性免疫系统 | 539 | 350 | 该途径中的所有SZGR 2.0基因 |
| REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 251 | 156 | 该途径中的所有SZGR 2.0基因 |
| REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 212 | 129 | 该途径中的所有SZGR 2.0基因 |
| Reactome APC CDC20介导的NEK2A降解 | 28 | 12 | 该途径中的所有SZGR 2.0基因 |
| ONKEN UVEAL MELANOMA UP | 783 | 507 | 该途径中的所有SZGR 2.0基因 |
| SAMOLS TARGETS OF KHSV MIRNAS DN | 62 | 35 | 该途径中的所有SZGR 2.0基因 |
| DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | 1382 | 904 | 该途径中的所有SZGR 2.0基因 |
| WAESCH ANAPHASE PROMOTING COMPLEX | 12 | 7 | 该途径中的所有SZGR 2.0基因 |
| DACOSTA UV RESPONSE VIA ERCC3 DN | 855 | 609 | 该途径中的所有SZGR 2.0基因 |
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | 584 | 395 | 该途径中的所有SZGR 2.0基因 |
| PUJANA BRCA1 PCC NETWORK | 1652 | 1023 | 该途径中的所有SZGR 2.0基因 |
| Benporath Nanog目标 | 988 | 594 | 该途径中的所有SZGR 2.0基因 |
| BENPORATH MYC MAX TARGETS | 775 | 494 | 该途径中的所有SZGR 2.0基因 |
| BENPORATH CYCLING GENES | 648 | 385 | 该途径中的所有SZGR 2.0基因 |
| GALE APL WITH FLT3 MUTATED UP | 56 | 35 | 该途径中的所有SZGR 2.0基因 |
| KAAB FAILED HEART ATRIUM DN | 141 | 99 | 该途径中的所有SZGR 2.0基因 |
| BLALOCK ALZHEIMERS DISEASE UP | 1691年 | 1088 | 该途径中的所有SZGR 2.0基因 |
| Kayo衰老肌肉DN | 123 | 76 | 该途径中的所有SZGR 2.0基因 |
| 维萨拉衰老淋巴细胞DN | 19 | 10 | 该途径中的所有SZGR 2.0基因 |
| IWANAGA CARCINOGENESIS BY KRAS DN | 120 | 81 | 该途径中的所有SZGR 2.0基因 |
| ACEVEDO LIVER CANCER UP | 973 | 570 | 该途径中的所有SZGR 2.0基因 |
| 肌肉DN中的罗马胰岛素靶标 | 204 | 114 | 该途径中的所有SZGR 2.0基因 |
| DANG BOUND BY MYC | 1103 | 714 | 该途径中的所有SZGR 2.0基因 |
| 惠特菲尔德细胞周期G2 | 182 | 102 | 该途径中的所有SZGR 2.0基因 |
| KIM ALL DISORDERS OLIGODENDROCYTE NUMBER CORR UP | 756 | 494 | 该途径中的所有SZGR 2.0基因 |
| KIM BIPOLAR DISORDER OLIGODENDROCYTE DENSITY CORR UP | 682 | 440 | 该途径中的所有SZGR 2.0基因 |
| 山乳房干细胞DN | 146 | 88 | 该途径中的所有SZGR 2.0基因 |